Proteon 320 Study

Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease


This research study is enrolling patients with chronic kidney disease from Lake Washington Vascular who will undergo a Radiocephalic Arteriovenous Fistula creation to create a new access to their bloodstream for hemodialysis. This study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase.


Study Coordinator(s)

Krissa Gunderson, CRC

Phone: 425.732.5958



Irina Stipek, CRC

Phone: 425.732.5959



Clinical Trial Categories

Vascular / Surgical

View all hospital services

Make a gift

Need urgent care?